Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1987 Apr 15;136(8):801–804.

Screening for maternal serum alpha-fetoprotein: what about the low side?

A Lippman, J A Evans
PMCID: PMC1492091  PMID: 2436735

Full text

PDF
801

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M. M., Finley S., Hansen H., Jahiel R. I., Oakley G. P., Jr, Sanger W., Wells G., Wertelecki W. Utilization of prenatal genetic diagnosis in women 35 years of age and older in the United States, 1977 to 1978. Am J Obstet Gynecol. 1981 Mar 15;139(6):673–677. doi: 10.1016/0002-9378(81)90483-x. [DOI] [PubMed] [Google Scholar]
  2. Bell J. A., Pearn J., Cohen G., Ford J., Halliday J., Martin N., Mulcahy M., Purvis-Smith S., Sutherland G. Utilization of prenatal cytogenetic diagnosis in women of advanced maternal age in Australia, 1979-1982. Prenat Diagn. 1985 Jan-Feb;5(1):53–58. doi: 10.1002/pd.1970050110. [DOI] [PubMed] [Google Scholar]
  3. Campbell T. L. Prenatal diagnosis for Down's syndrome. N Engl J Med. 1986 Jun 5;314(23):1516–1516. doi: 10.1056/NEJM198606053142317. [DOI] [PubMed] [Google Scholar]
  4. Chamberlain J. Human benefits and costs of a national screening programme for neural-tube defects. Lancet. 1978 Dec 16;2(8103):1293–1296. doi: 10.1016/s0140-6736(78)92053-6. [DOI] [PubMed] [Google Scholar]
  5. Crandall B. F., Lebherz T. B., Tabsh K. Maternal age and amniocentesis: should this be lowered to 30 years? Prenat Diagn. 1986 Jul-Aug;6(4):237–242. doi: 10.1002/pd.1970060402. [DOI] [PubMed] [Google Scholar]
  6. Cuckle H. S., Wald N. J., Lindenbaum R. H. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet. 1984 Apr 28;1(8383):926–929. doi: 10.1016/s0140-6736(84)92389-4. [DOI] [PubMed] [Google Scholar]
  7. Cuckle H. S., Wald N. J. Screening for Down's syndrome using serum alpha fetoprotein. Br Med J (Clin Res Ed) 1985 Aug 3;291(6491):349–349. doi: 10.1136/bmj.291.6491.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davenport D. M., Macri J. N. The clinical significance of low maternal serum alpha-fetoprotein. Am J Obstet Gynecol. 1983 Jul 15;146(6):657–661. doi: 10.1016/0002-9378(83)91008-6. [DOI] [PubMed] [Google Scholar]
  9. Doran T. A., Cadesky K., Wong P. Y., Mastrogiacomo C., Capello T. Maternal serum alpha-fetoprotein and fetal autosomal trisomies. Am J Obstet Gynecol. 1986 Feb;154(2):277–281. doi: 10.1016/0002-9378(86)90655-1. [DOI] [PubMed] [Google Scholar]
  10. Fuhrmann W., Weitzel H. K. Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects. Hum Genet. 1985;69(1):47–61. doi: 10.1007/BF00295529. [DOI] [PubMed] [Google Scholar]
  11. Fuhrmann W., Wendt P., Weitzel H. K. Maternal serum-AFP as screening test for Down syndrome. Lancet. 1984 Aug 18;2(8399):413–413. doi: 10.1016/s0140-6736(84)90585-3. [DOI] [PubMed] [Google Scholar]
  12. Hershey D. W., Crandall B. F., Schroth P. S. Maternal serum alpha-fetoprotein screening of fetal trisomies. Am J Obstet Gynecol. 1985 Sep 15;153(2):224–225. doi: 10.1016/0002-9378(85)90119-x. [DOI] [PubMed] [Google Scholar]
  13. Huether C. A. Projection of Down's syndrome births in the United States 1979-2000, and the potential effects of prenatal diagnosis. Am J Public Health. 1983 Oct;73(10):1186–1189. doi: 10.2105/ajph.73.10.1186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lenke R. R., Nemes J. M. Wrongful birth, wrongful life: the doctor between a rock and a hard place. Obstet Gynecol. 1985 Nov;66(5):719–722. [PubMed] [Google Scholar]
  15. Lippman-Hand A., Cohen D. I. Influence of obstetricians' attitudes on their use of prenatal diagnosis for the detection of Down's syndrome. Can Med Assoc J. 1980 Jun 21;122(12):1381–1386. [PMC free article] [PubMed] [Google Scholar]
  16. Lippman Abby. Access to prenatal screening services: who decides? Can J Women Law. 1986;1(2):434–445. [PubMed] [Google Scholar]
  17. Low maternal serum AFP and Down syndrome. Lancet. 1984 Jul 21;2(8395):161–162. [PubMed] [Google Scholar]
  18. Low maternal serum AFP and Down syndrome. Lancet. 1984 Jul 21;2(8395):161–162. [PubMed] [Google Scholar]
  19. Lowry R. B., Jones D. C., Renwick D. H., Trimble B. K. Down syndrome in British Columbia, 1952-73: incidence and mean maternal age. Teratology. 1976 Aug;14(1):29–34. doi: 10.1002/tera.1420140105. [DOI] [PubMed] [Google Scholar]
  20. Macri J. N. Critical issues in prenatal maternal serum alpha-fetoprotein screening for genetic anomalies. Am J Obstet Gynecol. 1986 Aug;155(2):240–246. doi: 10.1016/0002-9378(86)90798-2. [DOI] [PubMed] [Google Scholar]
  21. Martin A. O., Liu K. Implications of 'low' maternal serum alpha-fetoprotein levels: are maternal age risk criteria obsolete? Prenat Diagn. 1986 Jul-Aug;6(4):243–247. doi: 10.1002/pd.1970060403. [DOI] [PubMed] [Google Scholar]
  22. Merkatz I. R., Nitowsky H. M., Macri J. N., Johnson W. E. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984 Apr 1;148(7):886–894. doi: 10.1016/0002-9378(84)90530-1. [DOI] [PubMed] [Google Scholar]
  23. Mikkelsen M., Fischer G., Hansen J., Pilgaard B., Nielsen J. The impact of legal termination of pregnancy and of prenatal diagnosis on the birth prevalence of Down syndrome in Denmark. Ann Hum Genet. 1983 May;47(Pt 2):123–131. doi: 10.1111/j.1469-1809.1983.tb00979.x. [DOI] [PubMed] [Google Scholar]
  24. Murday V., Slack J. Screening for Down's syndrome in the North East Thames region. Br Med J (Clin Res Ed) 1985 Nov 9;291(6505):1315–1318. doi: 10.1136/bmj.291.6505.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Prenatal screening for Down syndrome. Lancet. 1984 Jun 16;1(8390):1359–1360. [PubMed] [Google Scholar]
  26. Spencer K., Carpenter P. Screening for Down's syndrome using serum alpha fetoprotein: a retrospective study indicating caution. Br Med J (Clin Res Ed) 1985 Jun 29;290(6486):1940–1943. doi: 10.1136/bmj.290.6486.1940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tabor A., Philip J., Madsen M., Bang J., Obel E. B., Nørgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet. 1986 Jun 7;1(8493):1287–1293. doi: 10.1016/s0140-6736(86)91218-3. [DOI] [PubMed] [Google Scholar]
  28. Vekemans M., Lippman A. Eligibility criteria for amniocentesis. Am J Med Genet. 1984 Feb;17(2):531–533. doi: 10.1002/ajmg.1320170215. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES